- Walgreens Boots Alliance agreed Jan. 6 to sell the majority of its Alliance Healthcare pharmacy unit to drug wholesale company AmerisourceBergen for $6.5 billion.
- Sanofi said Jan. 11 it will buy Kymab, a Cambridge, United Kingdom-based drugmaker that develops monoclonal antibodies, for up to $1.5 billion.
- Merck on Feb. 25 agreed to acquire Pandion Therapeutics, a clinical-stage drugmaker based in Massachusetts that specializes in autoimmune disease drugs, for $1.85 billion.
- Amgen announced March 4 it will acquire South San Francisco, Calif.-based drugmaker Five Prime Therapeutics for $38 per share in cash, or about $1.9 billion.
- Roche said March 15 it will buy Carlsbad, Calif.-based molecular test company GenMark Diagnostics for $1.8 billion.
- Thermo Fisher Scientific on April 15 announced plans to acquire PPD, a North Carolina-based pharmaceutical testing company.
More articles on pharmacy:
US hits 200M COVID-19 vaccinations within Biden’s first 100 days
FDA cites 9 violations after probe of Baltimore plant making J&J vaccine
Drug spending is climbing amid the pandemic, but not at hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.